Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Progenics 1Q loss narrows, revenue tops Street
Yahoo/AP
Friday, May 10, 2013 - 1:40pm
tags:
Progenics, earnings
Achillion: Down But Not Out And Progress Being Made
Seeking Alpha
Friday, May 10, 2013 - 1:39pm
tags:
Achillion, Bristol-Myers Squibb
Analysis: Drugmakers face more scrutiny of discordant U.S. prices
Yahoo/Reuters
Friday, May 10, 2013 - 12:49pm
tags:
drug pricing
Dendreon Earnings Show Poor Provenge Sales, Implosion Risk Rising
24/7 Wall St.
Friday, May 10, 2013 - 12:47pm
tags:
Dendreon, earnings
Pain Therapeutics discloses Pfizer reassessing continued Remoxy partnership
The Fly on the Wall
Friday, May 10, 2013 - 12:45pm
tags:
Pain Therapeutics, Remoxy, Pfizer
Risky Amarin Sets Its Cash Pile On Fire
Seeking Alpha
Friday, May 10, 2013 - 12:45pm
tags:
Amarin, Vascepa
U.S. judge denies FDA's bid to stay ruling on "morning-after" pill
Reuters
Friday, May 10, 2013 - 12:42pm
tags:
morning-after pill, FDA, Plan B contraceptive
MannKind's Countdown to Liftoff?
Motley Fool
Friday, May 10, 2013 - 12:40pm
tags:
MannKind, Afrezza
“Marketing Without Innovation”: a Merck Story
Yahoo/YCharts
Friday, May 10, 2013 - 12:35pm
tags:
Merck, Liptruzet
FDA approves Breo Ellipta to treat chronic obstructive pulmonary disease
Yahoo/Fly on the Wall
Friday, May 10, 2013 - 12:31pm
tags:
FDA, COPD, Breo Ellipta, Theravance
Second FDA thumbs-up for Novartis Ilaris
Pharma Times, UK
Friday, May 10, 2013 - 8:59am
tags:
FDA, Ilaris, Novartis, systemic juvenile idiopathic arthritis
3 Drug Catalysts to Watch in 2013
Motley Fool
Friday, May 10, 2013 - 8:58am
tags:
MannKind, Merck, Pfizer, Sanofi, Rigel Pharmaceuticals, suvorexant, insomnia, diabetes, Afrezza, fostamatinib, rheumatoid arthritis
Eli Lilly's lymphoma drug fails in late-stage trial
Reuters
Friday, May 10, 2013 - 8:56am
tags:
lymphoma, enzastaurin, Eli Lilly
Boston Scientific’s Mahoney Says Watchman Key to Growth
Bloomberg
Friday, May 10, 2013 - 8:55am
tags:
Boston Scientific, devices, WATCHMAN, atrial fibrillation
Discovery Labs Prices $14.25 Million Public Offering of Common Stock
Yahoo
Friday, May 10, 2013 - 8:50am
tags:
Discovery Labs, stock offering
ImmunoGen's Symbiotic Relationships Thru TAP Will Beef Up Its Stock Price
Seeking Alpha
Friday, May 10, 2013 - 8:40am
tags:
Immunogen, Targeted Antibody Payload
Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Arrived
Seeking Alpha
Friday, May 10, 2013 - 8:31am
tags:
Cellceutix, AstraZeneca, GSK, Celgene, Eli Lilly, Roche, Pfizer, Pharmacyclics, Kevetrin, cancer
Horizon Pharma Earnings Preview: Get Ahead of the Analysts
Wall St. Cheat Sheet
Friday, May 10, 2013 - 8:29am
tags:
Horizon Pharma, earnings
Johnson & Johnson deal to settle sales practices probe stalls
The Fly on the Wall
Friday, May 10, 2013 - 8:28am
tags:
JNJ
Review Of Depomed First Quarter 2013 Results
Seeking Alpha
Thursday, May 9, 2013 - 12:00pm
tags:
Depomed, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.